PowerShow.com
  • Help
  • Preferences
  • Sign up
  • Log in
Advanced
Free template

Postmarketing Surveillance PowerPoint PPT Presentations

Grid List
All Time
All TimeAdded TodayAdded This WeekAdded This Month
Show:
Recommended
RecommendedRelevanceLatestHighest RatedMost Viewed
Sort by:
Featured Presentations
Search Results
Postmarketing Surveillance Conference PowerPoint PPT Presentation
Postmarketing Surveillance Conference - ... of State and Territorial Epidemiologists (CSTE) participated in active GBS surveillance. State epidemiologists and Emerging Infectious Disease specialists in ...
... of State and Territorial Epidemiologists (CSTE) participated in active GBS surveillance. State epidemiologists and Emerging Infectious Disease specialists in ...
| PowerPoint PPT presentation | free to view
Trends in Postmarket Surveillance PowerPoint PPT Presentation
Trends in Postmarket Surveillance - the effect of user fees on FDA's ability to conduct postmarket surveillance ... Dodd has record on pediatric FDA issues ... MDUFMA | Other Policies ...
the effect of user fees on FDA's ability to conduct postmarket surveillance ... Dodd has record on pediatric FDA issues ... MDUFMA | Other Policies ...
| PowerPoint PPT presentation | free to view
Postmarket Surveillance of Medical Device Adverse Events PowerPoint PPT Presentation
Postmarket Surveillance of Medical Device Adverse Events - Postmarket Surveillance of Medical Device Adverse Events Hesha Jani Duggirala, PhD Epidemiology Branch Division of Postmarket Surveillance Office of Surveillance and ...
Postmarket Surveillance of Medical Device Adverse Events Hesha Jani Duggirala, PhD Epidemiology Branch Division of Postmarket Surveillance Office of Surveillance and ...
| PowerPoint PPT presentation | free to view
Postmarket Surveillance of Medical Device Adverse Events PowerPoint PPT Presentation
Postmarket Surveillance of Medical Device Adverse Events - Division of Postmarket Surveillance. Office of Surveillance ... Center for Devices and Radiological Health ... Device death, serious injuries, and malfunctions ...
Division of Postmarket Surveillance. Office of Surveillance ... Center for Devices and Radiological Health ... Device death, serious injuries, and malfunctions ...
| PowerPoint PPT presentation | free to view
Vaccine Safety Evaluation: Postmarketing Surveillance Conference PowerPoint PPT Presentation
Vaccine Safety Evaluation: Postmarketing Surveillance Conference - Meningococcal disease isolate serogroup and dominant subtype 1990 -2005 ... e.g. all intensive care admissions within 7 days/ unusual events thought to be ...
Meningococcal disease isolate serogroup and dominant subtype 1990 -2005 ... e.g. all intensive care admissions within 7 days/ unusual events thought to be ...
| PowerPoint PPT presentation | free to view
Using AERS in Postmarketing Surveillance of Medication Errors PowerPoint PPT Presentation
Using AERS in Postmarketing Surveillance of Medication Errors - Any PREVENTABLE event that may cause or lead to ... Linda Kim-Jung. Kristina Arnwine. Todd Bridges. Tselaine Jones-Smith. Laura Pincock. Maria Thomas ...
Any PREVENTABLE event that may cause or lead to ... Linda Kim-Jung. Kristina Arnwine. Todd Bridges. Tselaine Jones-Smith. Laura Pincock. Maria Thomas ...
| PowerPoint PPT presentation | free to view
Kineret anakinra: A Review of Safety Data Postmarketing Surveillance PowerPoint PPT Presentation
Kineret anakinra: A Review of Safety Data Postmarketing Surveillance - Pneumonia: 8 serious cases reported, 2 of which were fatal ... serious ISR on the thigh, with systemic symptoms (hypotension and tachycardia) ...
Pneumonia: 8 serious cases reported, 2 of which were fatal ... serious ISR on the thigh, with systemic symptoms (hypotension and tachycardia) ...
| PowerPoint PPT presentation | free to view
Using the FDA’s Adverse Event Reporting System (AERS) in Postmarketing Surveillance PowerPoint PPT Presentation
Using the FDA’s Adverse Event Reporting System (AERS) in Postmarketing Surveillance - Using the FDA s Adverse Event Reporting System (AERS) in Postmarketing Surveillance Joyce P. Weaver, Pharm.D., BCPS Division of Drug Risk Evaluation
Using the FDA s Adverse Event Reporting System (AERS) in Postmarketing Surveillance Joyce P. Weaver, Pharm.D., BCPS Division of Drug Risk Evaluation
| PowerPoint PPT presentation | free to view
Overview of Postmarketing Safety Surveillance in FDA For Drugs and Biologics PowerPoint PPT Presentation
Overview of Postmarketing Safety Surveillance in FDA For Drugs and Biologics - OTC drugs - No reporting requirement unless drug was approved under NDA ... Congress, GAO, DHHS, FBI, CPSC, foreign regulatory authorities. Develop risk ...
OTC drugs - No reporting requirement unless drug was approved under NDA ... Congress, GAO, DHHS, FBI, CPSC, foreign regulatory authorities. Develop risk ...
| PowerPoint PPT presentation | free to view
Active postmarketing surveillance for vaccine adverse events: The experience of the Vaccine Safety D PowerPoint PPT Presentation
Active postmarketing surveillance for vaccine adverse events: The experience of the Vaccine Safety D - Why we need active post-marketing surveillance ... Known biologic properties of the vaccine. VAERS reports. Literature on this or similar vaccines ...
Why we need active post-marketing surveillance ... Known biologic properties of the vaccine. VAERS reports. Literature on this or similar vaccines ...
| PowerPoint PPT presentation | free to view
Lotronex Postmarketing Experience PowerPoint PPT Presentation
Lotronex Postmarketing Experience - Lotronex Postmarketing Experience Ann Corken Mackey, R.Ph., M.P.H. Allen Brinker, M.D., M.S. Zili Li, M.D., M.P.H., formerly of ODS Office of Drug Safety (ODS)
Lotronex Postmarketing Experience Ann Corken Mackey, R.Ph., M.P.H. Allen Brinker, M.D., M.S. Zili Li, M.D., M.P.H., formerly of ODS Office of Drug Safety (ODS)
| PowerPoint PPT presentation | free to download
Device Postmarket Studies PowerPoint PPT Presentation
Device Postmarket Studies - Device Postmarket Studies. Danica Marinac-Dabic, MD, PhD. Chief, Epidemiology Branch ... Longer-term performance including effects of re-treatments & product changes ...
Device Postmarket Studies. Danica Marinac-Dabic, MD, PhD. Chief, Epidemiology Branch ... Longer-term performance including effects of re-treatments & product changes ...
| PowerPoint PPT presentation | free to view
Postmarketing Safety Assessment of Osteonecrosis of the Jaw Pamidronate PowerPoint PPT Presentation
Postmarketing Safety Assessment of Osteonecrosis of the Jaw Pamidronate - Title: Postmarketing Surveillance and Pharmacovigilance Practice in FDA Author: CDER.USER Last modified by: FDA User Created Date: 9/18/2003 4:06:40 PM
Title: Postmarketing Surveillance and Pharmacovigilance Practice in FDA Author: CDER.USER Last modified by: FDA User Created Date: 9/18/2003 4:06:40 PM
| PowerPoint PPT presentation | free to view
Postmarket Transformation at CDRH: The Role of Statistician PowerPoint PPT Presentation
Postmarket Transformation at CDRH: The Role of Statistician - Postmarket Transformation at CDRH: The Role of Statistician Danica Marinac Dabic, M.D., Ph.D. Chief, Epidemiology Branch Office of Surveillance and Biometrics
Postmarket Transformation at CDRH: The Role of Statistician Danica Marinac Dabic, M.D., Ph.D. Chief, Epidemiology Branch Office of Surveillance and Biometrics
| PowerPoint PPT presentation | free to view
POSTMARKETING SAFETY STUDIES PowerPoint PPT Presentation
POSTMARKETING SAFETY STUDIES - Public health burden of serious adverse drug events. Reactions to our drug ... Phase 1 Studies: Drug cautiously given to small group of healthy volunteers ...
Public health burden of serious adverse drug events. Reactions to our drug ... Phase 1 Studies: Drug cautiously given to small group of healthy volunteers ...
| PowerPoint PPT presentation | free to view
Medical Device Registries: Multiple Applications PowerPoint PPT Presentation
Medical Device Registries: Multiple Applications - Medical Device Registries: Multiple Applications Thomas P. Gross, MD, MPH Director Division of Postmarket Surveillance Office of Surveillance & Biometrics
Medical Device Registries: Multiple Applications Thomas P. Gross, MD, MPH Director Division of Postmarket Surveillance Office of Surveillance & Biometrics
| PowerPoint PPT presentation | free to download
Risk analysis and postmarketing pharmacovigilance activities PowerPoint PPT Presentation
Risk analysis and postmarketing pharmacovigilance activities - Boehringer Ingelheim (Pty) Ltd. Acknowledgement & thanks: ... The Lancet starts collecting notifications of side effects after a death caused by anaesthesia ...
Boehringer Ingelheim (Pty) Ltd. Acknowledgement & thanks: ... The Lancet starts collecting notifications of side effects after a death caused by anaesthesia ...
| PowerPoint PPT presentation | free to view
POST-MARKETING SURVEILLANCE: ONE DIVISION DIRECTOR PowerPoint PPT Presentation
POST-MARKETING SURVEILLANCE: ONE DIVISION DIRECTOR - ... Adverse Events with known background rates Tolcapone and liver failure Felbamate and aplastic anemia HOW WE EVALUATE A SAFETY SIGNAL FROM SPONTANEOUS ...
... Adverse Events with known background rates Tolcapone and liver failure Felbamate and aplastic anemia HOW WE EVALUATE A SAFETY SIGNAL FROM SPONTANEOUS ...
| PowerPoint PPT presentation | free to download
Best Practices in Meeting Your Postmarketing Study Commitments PowerPoint PPT Presentation
Best Practices in Meeting Your Postmarketing Study Commitments - Best Practices in Meeting Your Postmarketing Study Commitments. Cyndi Verst-Brasch, Pharm.D., M.S. ... N o r t h A m e r I c a E u r o p e A s I a / P a c I ...
Best Practices in Meeting Your Postmarketing Study Commitments. Cyndi Verst-Brasch, Pharm.D., M.S. ... N o r t h A m e r I c a E u r o p e A s I a / P a c I ...
| PowerPoint PPT presentation | free to download
Postmarket Transformation at CDRH: The Role of Statistician PowerPoint PPT Presentation
Postmarket Transformation at CDRH: The Role of Statistician - Danica Marinac Dabic, M.D., Ph.D. Chief, Epidemiology Branch ... CDRH postmarket responsibilities and challenges. Established roles of the CDRH statisticians ...
Danica Marinac Dabic, M.D., Ph.D. Chief, Epidemiology Branch ... CDRH postmarket responsibilities and challenges. Established roles of the CDRH statisticians ...
| PowerPoint PPT presentation | free to view
The FDAs Postmarketing Adverse Drug Experience Inspectional Program PowerPoint PPT Presentation
The FDAs Postmarketing Adverse Drug Experience Inspectional Program - ... 15 calendar days if Serious and Unexpected (domestic and foreign) Follow-up information. Non-applicant notifies applicant within five calendar days. 8. Periodic ...
... 15 calendar days if Serious and Unexpected (domestic and foreign) Follow-up information. Non-applicant notifies applicant within five calendar days. 8. Periodic ...
| PowerPoint PPT presentation | free to view
Active Surveillance for Drug Safety Signals: Past, Present, and Future PowerPoint PPT Presentation
Active Surveillance for Drug Safety Signals: Past, Present, and Future - DSaRM Advisory Committee. May 18, 2005. Active Surveillance for Drug Safety ... Funded mainly by unconditional grants from pharmaceuticals ...
DSaRM Advisory Committee. May 18, 2005. Active Surveillance for Drug Safety ... Funded mainly by unconditional grants from pharmaceuticals ...
| PowerPoint PPT presentation | free to view
Topical Corticosteroid Adverse Events in Pediatric Patients Analysis of Postmarketing Reports PowerPoint PPT Presentation
Topical Corticosteroid Adverse Events in Pediatric Patients Analysis of Postmarketing Reports - Topical Corticosteroid Adverse Events in Pediatric Patients Analysis of Postmarketing Reports Pediatric Advisory Subcommittee of the Anti-Infective Drugs Advisory ...
Topical Corticosteroid Adverse Events in Pediatric Patients Analysis of Postmarketing Reports Pediatric Advisory Subcommittee of the Anti-Infective Drugs Advisory ...
| PowerPoint PPT presentation | free to view
Parallel Session 1 Post Market Adverse Events: FDA Reporting Systems and Surveillance PowerPoint PPT Presentation
Parallel Session 1 Post Market Adverse Events: FDA Reporting Systems and Surveillance - Parallel Session 1 Post Market Adverse Events: FDA Reporting Systems and Surveillance
Parallel Session 1 Post Market Adverse Events: FDA Reporting Systems and Surveillance
| PowerPoint PPT presentation | free to view
Global%20Harmonization%20of%20Medical%20Device%20Regulation:%20Accomplishments,%20Challenges%20and%20Opportunities PowerPoint PPT Presentation
Global%20Harmonization%20of%20Medical%20Device%20Regulation:%20Accomplishments,%20Challenges%20and%20Opportunities - Essential principles conformance vs. review. Postmarket surveillance ... Public declaration vs. de facto practice. Industry must get engaged ...
Essential principles conformance vs. review. Postmarket surveillance ... Public declaration vs. de facto practice. Industry must get engaged ...
| PowerPoint PPT presentation | free to download
PostMarketing Safety Information on Medical Products: Potentials for Improvements PowerPoint PPT Presentation
PostMarketing Safety Information on Medical Products: Potentials for Improvements - The views expressed are those of the author, and do not represent an official FDA ... EMRs. Compatability' of data needs with data sources. Richness of detail ...
The views expressed are those of the author, and do not represent an official FDA ... EMRs. Compatability' of data needs with data sources. Richness of detail ...
| PowerPoint PPT presentation | free to view
Statement before the Food and Drug Administration Public Hearing on Prescription Drug User Fee Act P PowerPoint PPT Presentation
Statement before the Food and Drug Administration Public Hearing on Prescription Drug User Fee Act P - Made a significant contribution in securing financial resources ... Polypharmacy. Off label uses. Shared Responsibility for Postmarket Surveillance. Manufacturers ...
Made a significant contribution in securing financial resources ... Polypharmacy. Off label uses. Shared Responsibility for Postmarket Surveillance. Manufacturers ...
| PowerPoint PPT presentation | free to view
Parallel Session 1 The Role of the Statistician in Post-Marketing, Including Surveillance PowerPoint PPT Presentation
Parallel Session 1 The Role of the Statistician in Post-Marketing, Including Surveillance - Provide insight into the role of the statistician in FDA post-marketing ... 8:20: Danica Marinac-Dabic, MD, PhD (Chief, Epidemiology Branch, OSB, CDRH) ...
Provide insight into the role of the statistician in FDA post-marketing ... 8:20: Danica Marinac-Dabic, MD, PhD (Chief, Epidemiology Branch, OSB, CDRH) ...
| PowerPoint PPT presentation | free to view
MedDRA PowerPoint PPT Presentation
MedDRA - ... Dictionary for Regulatory Activities terminology (MedDRA ) in the drug safety ... Injury Surveillance System -Cooperative Adverse Drug Event Surveillance) ...
... Dictionary for Regulatory Activities terminology (MedDRA ) in the drug safety ... Injury Surveillance System -Cooperative Adverse Drug Event Surveillance) ...
| PowerPoint PPT presentation | free to download
Adverse Event Reports on Automatic External Defibrillators from 1996 2003 PowerPoint PPT Presentation
Adverse Event Reports on Automatic External Defibrillators from 1996 2003 - Office of Surveillance and Biometrics Office of Device Evaluation. Medical Device Reporting ... Office of Surveillance and Biometrics. Oscar H Tovar. CDRH / FDA ...
Office of Surveillance and Biometrics Office of Device Evaluation. Medical Device Reporting ... Office of Surveillance and Biometrics. Oscar H Tovar. CDRH / FDA ...
| PowerPoint PPT presentation | free to download
Incident Reports and field Safety Corrective Action ( FSCA) PowerPoint PPT Presentation
Incident Reports and field Safety Corrective Action ( FSCA) - Incident Reports and field Safety Corrective Action ( FSCA) Eng. Essam M. Al-Mohandis Executive Director of Surveillance and Biometrics
Incident Reports and field Safety Corrective Action ( FSCA) Eng. Essam M. Al-Mohandis Executive Director of Surveillance and Biometrics
| PowerPoint PPT presentation | free to download
Assessment of the cardiovascular risks and health benefits of rosiglitazone PowerPoint PPT Presentation
Assessment of the cardiovascular risks and health benefits of rosiglitazone - Assessment of the cardiovascular risks and health benefits of rosiglitazone David J. Graham, MD, MPH Office of Surveillance and Epidemiology Food and Drug Administration
Assessment of the cardiovascular risks and health benefits of rosiglitazone David J. Graham, MD, MPH Office of Surveillance and Epidemiology Food and Drug Administration
| PowerPoint PPT presentation | free to download
One Year Post Exclusivity Adverse Event Review Update: Orlistat Pediatric Advisory Committee Meeting PowerPoint PPT Presentation
One Year Post Exclusivity Adverse Event Review Update: Orlistat Pediatric Advisory Committee Meeting - Reports of cholelithiasis during trial and post-marketing surveillance ... Cholelithiasis: Orlistat. Adverse Events: cholelithiasis/acute cholecystitis (April ...
Reports of cholelithiasis during trial and post-marketing surveillance ... Cholelithiasis: Orlistat. Adverse Events: cholelithiasis/acute cholecystitis (April ...
| PowerPoint PPT presentation | free to view
FDLI Introduction to Medical Device Law and Regulation PowerPoint PPT Presentation
FDLI Introduction to Medical Device Law and Regulation - FDLI Introduction to Medical Device Law and Regulation. Other Postmarket Controls ... Not just representations made or suggested, but also material omissions. 19 ...
FDLI Introduction to Medical Device Law and Regulation. Other Postmarket Controls ... Not just representations made or suggested, but also material omissions. 19 ...
| PowerPoint PPT presentation | free to download
Incident Reports and field Safety Corrective Action ( FSCA) PowerPoint PPT Presentation
Incident Reports and field Safety Corrective Action ( FSCA) - W hen Medical devices subjected to Field safety notice distributed in KSA market, the establishment shall: Maintain traceability system for surveillance purposes.
W hen Medical devices subjected to Field safety notice distributed in KSA market, the establishment shall: Maintain traceability system for surveillance purposes.
| PowerPoint PPT presentation | free to view
Cardiovascular and Renal Drugs Advisory Committee PowerPoint PPT Presentation
Cardiovascular and Renal Drugs Advisory Committee - vascularity in organs. myocardial perfusion. other? 5. Marketed Ultrasound Contrast Agents ... PMC to perform a surveillance study of Definity 'as it is used in ...
vascularity in organs. myocardial perfusion. other? 5. Marketed Ultrasound Contrast Agents ... PMC to perform a surveillance study of Definity 'as it is used in ...
| PowerPoint PPT presentation | free to download
Neurologic Adverse Events Associated with Absorbable Hemostatic Agents PowerPoint PPT Presentation
Neurologic Adverse Events Associated with Absorbable Hemostatic Agents - Center for Devices and Radiological Health. Office of Surveillance and Biometrics ... Patient was taken to surgery for a T5-T8 laminectomy where a mass of hemostatic ...
Center for Devices and Radiological Health. Office of Surveillance and Biometrics ... Patient was taken to surgery for a T5-T8 laminectomy where a mass of hemostatic ...
| PowerPoint PPT presentation | free to view
Condition of Approval Studies: Recent Changes in CDRH PowerPoint PPT Presentation
Condition of Approval Studies: Recent Changes in CDRH - Develop and institute an automated tracking system for CoA commitments ... Lead in evaluation of study progress and results after approval. Will continue to work ...
Develop and institute an automated tracking system for CoA commitments ... Lead in evaluation of study progress and results after approval. Will continue to work ...
| PowerPoint PPT presentation | free to download
CDRH PowerPoint PPT Presentation
CDRH - Title: CDRH s Regulatory Agenda for 2007-2008 Author: Timothy A Ulatowski Created Date: 3/5/2007 5:06:13 PM Document presentation format: On-screen Show
Title: CDRH s Regulatory Agenda for 2007-2008 Author: Timothy A Ulatowski Created Date: 3/5/2007 5:06:13 PM Document presentation format: On-screen Show
| PowerPoint PPT presentation | free to download
Medical Device Registries: Multiple Applications PowerPoint PPT Presentation
Medical Device Registries: Multiple Applications - Registry maintained at University of Utah & cases also accrued via ASCRS website Augment TASS registry with spontaneous reports & assess utility for identifying ...
Registry maintained at University of Utah & cases also accrued via ASCRS website Augment TASS registry with spontaneous reports & assess utility for identifying ...
| PowerPoint PPT presentation | free to download
Pharmacovigilance and Drug Safety Compliance Update PowerPoint PPT Presentation
Pharmacovigilance and Drug Safety Compliance Update - Pharmacovigilance and Drug Safety Compliance Update GAP Analysis: How We Get to Where We Want to Be John P. Ford Sidley Austin LLP Core PV Concepts Risk ...
Pharmacovigilance and Drug Safety Compliance Update GAP Analysis: How We Get to Where We Want to Be John P. Ford Sidley Austin LLP Core PV Concepts Risk ...
| PowerPoint PPT presentation | free to download
Changes in HIV Testing Practices and Counseling Recommendations PowerPoint PPT Presentation
Changes in HIV Testing Practices and Counseling Recommendations - Make voluntary HIV testing a routine part of medical care. Implement new models for diagnosing HIV infections outside medical settings ...
Make voluntary HIV testing a routine part of medical care. Implement new models for diagnosing HIV infections outside medical settings ...
| PowerPoint PPT presentation | free to download
CDRH: Minimizing Risk of TSE Agents in Medical Devices PowerPoint PPT Presentation
CDRH: Minimizing Risk of TSE Agents in Medical Devices - Neurological Devices/General Surgical Instruments. In Vitro Diagnostic Devices. 4 ... General Surgical instruments (scalpels, scissors, biopsy forceps, retractors) 8 ...
Neurological Devices/General Surgical Instruments. In Vitro Diagnostic Devices. 4 ... General Surgical instruments (scalpels, scissors, biopsy forceps, retractors) 8 ...
| PowerPoint PPT presentation | free to view
Adverse Event Tracking as mandated by the Best Pharmaceuticals for Children Act PowerPoint PPT Presentation
Adverse Event Tracking as mandated by the Best Pharmaceuticals for Children Act - Title: Division of Pediatric Drug Development Author: GILMERL Last modified by: PHUCASK Created Date: 2/14/2003 4:19:34 PM Document presentation format
Title: Division of Pediatric Drug Development Author: GILMERL Last modified by: PHUCASK Created Date: 2/14/2003 4:19:34 PM Document presentation format
| PowerPoint PPT presentation | free to download
The Food and Drug Administration Amendments Act of 2007: Implications of the Drug Safety Provisions PowerPoint PPT Presentation
The Food and Drug Administration Amendments Act of 2007: Implications of the Drug Safety Provisions - Prescription Drug User Fee Act. Medical Device User Fee Act ... validation, authentication, and tracking and tracing of the prescription drug ...
Prescription Drug User Fee Act. Medical Device User Fee Act ... validation, authentication, and tracking and tracing of the prescription drug ...
| PowerPoint PPT presentation | free to view
Sn PowerPoint PPT Presentation
Sn - Charles University in Prague, Third Faculty of Medicine Cycle II, Subject: General Pharmacology Lecture: 18th October 2011 8:00-9:30 Jonas Hall, Rusk 87, Prague
Charles University in Prague, Third Faculty of Medicine Cycle II, Subject: General Pharmacology Lecture: 18th October 2011 8:00-9:30 Jonas Hall, Rusk 87, Prague
| PowerPoint PPT presentation | free to view
FDA Amendments Act FDAAA: New Regulatory Authorities PowerPoint PPT Presentation
FDA Amendments Act FDAAA: New Regulatory Authorities - active post market risk identification and analysis system (to be established ... May not introduce drug into interstate commerce if in violation of provision ...
active post market risk identification and analysis system (to be established ... May not introduce drug into interstate commerce if in violation of provision ...
| PowerPoint PPT presentation | free to view
Adverse Event Reports on Automatic External Defibrillators from 1996 - 2003 PowerPoint PPT Presentation
Adverse Event Reports on Automatic External Defibrillators from 1996 - 2003 - Adverse Event Reports on Automatic External Defibrillators from 1996 - 2003 Oscar H Tovar MD and Beverly Gallauresi RN, MPH Food and Drug Administration
Adverse Event Reports on Automatic External Defibrillators from 1996 - 2003 Oscar H Tovar MD and Beverly Gallauresi RN, MPH Food and Drug Administration
| PowerPoint PPT presentation | free to download
Facilitating Medical Innovation and Technology: The Role of FDA PowerPoint PPT Presentation
Facilitating Medical Innovation and Technology: The Role of FDA - In attempting to arrive at the truth, I have applied everywhere for information, but in scarcely an instance have I been able to obtain hospital records fit for any ...
In attempting to arrive at the truth, I have applied everywhere for information, but in scarcely an instance have I been able to obtain hospital records fit for any ...
| PowerPoint PPT presentation | free to download
Risk%20Management,%20Risk%20Communication,%20and%20Drug%20Safety:%20The%20U.S.%20Experience PowerPoint PPT Presentation
Risk%20Management,%20Risk%20Communication,%20and%20Drug%20Safety:%20The%20U.S.%20Experience - FDA lacks authority and funding for adequate oversight of drug safety ... FDA imprimatur on unvalidated safety information. Potential for confusion, overreaction ...
FDA lacks authority and funding for adequate oversight of drug safety ... FDA imprimatur on unvalidated safety information. Potential for confusion, overreaction ...
| PowerPoint PPT presentation | free to download
VICP Clinical Update Advisory Commission on Childhood Vaccines 12-2011 PowerPoint PPT Presentation
VICP Clinical Update Advisory Commission on Childhood Vaccines 12-2011 - Title: Slide 1 Author: Hrsa Last modified by: aherzog Created Date: 10/14/2008 7:28:15 PM Document presentation format: On-screen Show (4:3) Company
Title: Slide 1 Author: Hrsa Last modified by: aherzog Created Date: 10/14/2008 7:28:15 PM Document presentation format: On-screen Show (4:3) Company
| PowerPoint PPT presentation | free to view
Adverse Event Review and Reporting as Mandated by Best Pharmaceuticals for Children Act: Summary of Committee Feedback and Options for Improvement PowerPoint PPT Presentation
Adverse Event Review and Reporting as Mandated by Best Pharmaceuticals for Children Act: Summary of Committee Feedback and Options for Improvement - Denominator Data (exposure) Problems. Numerator Data (adverse events) Problems ... Better handle on denominator (exposed) and numerators (events) Limitation ...
Denominator Data (exposure) Problems. Numerator Data (adverse events) Problems ... Better handle on denominator (exposed) and numerators (events) Limitation ...
| PowerPoint PPT presentation | free to download
Post-Market Drug Safety PowerPoint PPT Presentation
Post-Market Drug Safety - monitoring the utilization of marketed drugs. soliciting/performing population-based epidemiologic studies. April 15, 2005 ... Adverse Event Reporting System (AERS) ...
monitoring the utilization of marketed drugs. soliciting/performing population-based epidemiologic studies. April 15, 2005 ... Adverse Event Reporting System (AERS) ...
| PowerPoint PPT presentation | free to view
How does the U.S. FDA Regulate Medical Devices? PowerPoint PPT Presentation
How does the U.S. FDA Regulate Medical Devices? - ... 34.00 6987.00 13.00 7225.00 4789.00 1284.00 556.00 6629.00 344.00 64.00 7037.00 188.00 46736.00 9077.00 8209.00 7242.00 24528.00 11284.00 4682.00 40494.00 6242 ...
... 34.00 6987.00 13.00 7225.00 4789.00 1284.00 556.00 6629.00 344.00 64.00 7037.00 188.00 46736.00 9077.00 8209.00 7242.00 24528.00 11284.00 4682.00 40494.00 6242 ...
| PowerPoint PPT presentation | free to view
Diapositiva 1 PowerPoint PPT Presentation
Diapositiva 1 - Espa a (AGEMED) y Europa (EMEA) Mariano Madurga. Divisi n de Farmacoepidemiologia y Farmacovigilancia Agencia Espa ola del Medicamento.
Espa a (AGEMED) y Europa (EMEA) Mariano Madurga. Divisi n de Farmacoepidemiologia y Farmacovigilancia Agencia Espa ola del Medicamento.
| PowerPoint PPT presentation | free to download
TNF Blocker Safety: Lymphoma and Liver Failure PowerPoint PPT Presentation
TNF Blocker Safety: Lymphoma and Liver Failure - Tim Cot MD MPH, Chief, Therapeutics & Blood Safety Branch, DE/OBE/CBER/FDA. March 4, 2003 ... Clinicians and others can report adverse events associated with ...
Tim Cot MD MPH, Chief, Therapeutics & Blood Safety Branch, DE/OBE/CBER/FDA. March 4, 2003 ... Clinicians and others can report adverse events associated with ...
| PowerPoint PPT presentation | free to view
Page of  


PowerPlugs
PowerPlugs
View by Category
Presentations
  • Photo Slideshows
  • Presentations (free-to-view)
    • Concepts & Trends
    • Entertainment
    • Fashion & Beauty
    • Government & Politics
    • How To, Education & Training
    • Medicine, Science & Technology
    • Other
    • Pets & Animals
    • Products & Services
    • Religious & Philosophical
    • Travel & Places
  • Presentations (pay-to-view)
Products Sold on our sister site CrystalGraphics.com
  • Ultimate Combo for PPT
  • PowerPoint Templates
  • Charts & Diagrams for PPT
  • 3D Character Slides
  • Background Videos for PPT
  • More Products for PPT
PowerPlugs
PowerPlugs
CrystalGraphics
Home About Us Terms and Conditions Privacy Policy Contact Us Send Us Feedback
Copyright 2021 CrystalGraphics, Inc. — All rights Reserved. PowerShow.com is a trademark of CrystalGraphics, Inc.
postmarketing surveillance — Search results on PowerShow.com
Loading...